Cite
Ahring KK, Dagnæs-Hansen F, Brüel A, et al. The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model. PLoS One. 2022;17(1):e0261150doi: 10.1371/journal.pone.0261150.
Ahring, K. K., Dagnæs-Hansen, F., Brüel, A., Christensen, M., Jensen, E., Jensen, T. G., Johannsen, M., Johansen, K. S., Lund, A. M., Madsen, J. G., Brøndum-Nielsen, K., Pedersen, M., Sørensen, L. K., Kjolby, M., & Møller, L. B. (2022). The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model. PloS one, 17(1), e0261150. https://doi.org/10.1371/journal.pone.0261150
Ahring, Kirsten K, et al. "The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model." PloS one vol. 17,1 (2022): e0261150. doi: https://doi.org/10.1371/journal.pone.0261150
Ahring KK, Dagnæs-Hansen F, Brüel A, Christensen M, Jensen E, Jensen TG, Johannsen M, Johansen KS, Lund AM, Madsen JG, Brøndum-Nielsen K, Pedersen M, Sørensen LK, Kjolby M, Møller LB. The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model. PLoS One. 2022 Jan 11;17(1):e0261150. doi: 10.1371/journal.pone.0261150. eCollection 2022. PMID: 35015767.
Copy
Download .nbib